Retatrutide 20mg +Trizepatide 40mg is supplied as one grouped combination formula with its CRM catalog variants.
Retatrutide 20mg +Trizepatide 40mg is supplied as one grouped combination formula with its CRM catalog variants.
This product is intended for research use only in laboratory settings. Not for diagnostic or therapeutic use. Not for human or veterinary use.
Batch-level information is organized for clear review by qualified research teams.
Certificate of Analysis (COA)Request
HPLC Analysis ReportRequest
MS Analysis ReportRequest
Product DatasheetRequest
Each released batch is reviewed and documented to support consistency and traceability.
Learn More →
Weight Loss & GLP-1 Agonists
View Details
Repair, Recovery & Anti-Inflammatory
View Details
Weight Loss & GLP-1 Agonists
View Details
Cosmetic, Anti-Aging & Skin
View Details
Growth Hormone & Peptides
View Details